Biolase Shares Jump 27% After Upbeat 2024 Revenue Guidance

Dow Jones03-22

By Zaeem Shoaib

 

Shares of Biolase were higher Friday after the company provided guidance for an increase in revenue in 2024.

Biolase's shares were up 27% to 19.1 cents in recent trading. The stock has fallen almost 83% year to date.

Late Thursday, the dental laser technology company said it expects its full-year revenue to rise between 6% and 8%. In 2023, Biolase posted net revenue of $49.2 million, up 1%.

 

Write to Zaeem Shoaib at zaeem.shoaib@wsj.com

 

(END) Dow Jones Newswires

March 22, 2024 11:33 ET (15:33 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment